More frequently reported side effects include: fever.  See below for a comprehensive list of adverse effects.
Applies to elotuzumab: intravenous powder for solution
In addition to its needed effects, some unwanted effects may be caused by elotuzumab. In the event that any of these side effects do occur, they may require medical attention.

If any of the following side effects occur while taking elotuzumab, check with your doctor or nurse immediately:
Some of the side effects that can occur with elotuzumab may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to elotuzumab: intravenous powder for injection
Common (1% to 10%): Night sweats[Ref]
Very common (10% or more): Diarrhea (47%), constipation (36%), vomiting (15%), oropharyngeal pain (10%)[Ref]
Very common (10% or more): Lymphopenia (13%)Frequency not reported: Leukopenia, thrombocytopenia[Ref]
Frequency not reported: Hypoalbuminemia, elevated alkaline phosphatase[Ref]
Common (1% to 10%): Hypersensitivity[Ref]
Very common (10% or more): Decreased appetite (21%), weight loss (14%)Frequency not reported: Hyperglycemia, hypocalcemia, low bicarbonate, hyperkalemia[Ref]
Very common (10% or more): Pain in extremities (16%)Common (1% to 10%): Chest pain[Ref]
Very common (10% or more): Peripheral neuropathy (27%), headache (15%)Common (1% to 10%): Hypoesthesia[Ref]
Very common (10% or more): Cataracts (12%)[Ref]
Common (1% to 10%): Invasive second primary malignancies (SPM)[Ref]
Very common (10% or more): Fatigue (62%), pyrexia (37%)[Ref]
Common (1% to 10%): Altered mood[Ref]
Common (1% to 10%): Acute renal failure[Ref]
Very common (10% or more): Cough (34%), nasopharyngitis (25%), upper respiratory tract infection (23%), pneumonia (20%)Common (1% to 10%): Respiratory tract infection, pulmonary embolism[Ref]
1. "Product Information. Empliciti (elotuzumab)." Bristol-Myers Squibb, Princeton, NJ. 
Not all side effects for elotuzumab may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Blurred vision
body aches or pain
chest pain
chills
confusion
cough or hoarseness
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
ear congestion
facial swelling
fever or chills
headache
hives, itching, or rash
hoarseness
irritation
joint pain, stiffness, or swelling
loss of voice
lower back or side pain
nasal congestion
nausea or vomiting
nervousness
painful or difficult urination
pounding in the ears
redness of the skin
runny nose
slow or fast heartbeat
sneezing
sore throat
sweating
swelling of the eyelids, face, lips, hands, or feet
tightness in the chest
troubled breathing or swallowing
unusual tiredness or weakness


Abdominal pain or tenderness
clay-colored stools
dark urine
loss of appetite
persistent sore that does not heal
pink skin growth
reddish patch or irritated area
shiny skin bump
swelling of the feet or lower legs
white, yellow or waxy scar-like area on the skin
yellow eyes or skin


Blindness
burning, numbness, tingling, or painful sensations
decreased appetite
decreased vision
decreased weight
diarrhea
difficulty having a bowel movement (stool)
muscle aches
night sweats
pain in the arms or legs
unsteadiness or awkwardness
weakness in the arms, hands, legs, or feet

